COSMO Pharmaceuticals SA (COPN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, COSMO Pharmaceuticals SA (COPN) has a cash flow conversion efficiency ratio of -0.026x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF-12.70 Million ≈ $-16.06 Million USD) by net assets (CHF488.80 Million ≈ $617.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
COSMO Pharmaceuticals SA - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how COSMO Pharmaceuticals SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read COSMO Pharmaceuticals SA total liabilities for a breakdown of total debt and financial obligations.
COSMO Pharmaceuticals SA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of COSMO Pharmaceuticals SA ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Yapp Automotive Systems Co Ltd
SHG:603013
|
0.065x |
|
Bio-Rad Laboratories Inc
NYSE:BIO-B
|
0.016x |
|
MD Pictures Tbk PT
JK:FILM
|
-0.015x |
|
Acadia Healthcare Company Inc
NASDAQ:ACHC
|
0.022x |
|
QCR Holdings Inc
NASDAQ:QCRH
|
0.043x |
|
Hyundai Green Food Co Ltd
KO:005440
|
0.008x |
|
Guangdong Homa Appliances Co Ltd
SHE:002668
|
0.117x |
|
Harrow Health Inc
NASDAQ:HROW
|
0.356x |
Annual Cash Flow Conversion Efficiency for COSMO Pharmaceuticals SA (2004–2025)
The table below shows the annual cash flow conversion efficiency of COSMO Pharmaceuticals SA from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see COSMO Pharmaceuticals SA (COPN) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CHF488.80 Million ≈ $617.97 Million |
CHF-11.62 Million ≈ $-14.69 Million |
-0.024x | -107.39% |
| 2024-12-31 | CHF505.09 Million ≈ $638.57 Million |
CHF162.41 Million ≈ $205.33 Million |
0.322x | +507.52% |
| 2023-12-31 | CHF429.04 Million ≈ $542.42 Million |
CHF22.71 Million ≈ $28.71 Million |
0.053x | -26.12% |
| 2022-12-31 | CHF463.79 Million ≈ $586.35 Million |
CHF33.23 Million ≈ $42.01 Million |
0.072x | +191.24% |
| 2021-12-31 | CHF512.68 Million ≈ $648.16 Million |
CHF12.61 Million ≈ $15.94 Million |
0.025x | -24.20% |
| 2020-12-31 | CHF400.12 Million ≈ $505.87 Million |
CHF12.98 Million ≈ $16.42 Million |
0.032x | +167.80% |
| 2019-12-31 | CHF393.73 Million ≈ $497.78 Million |
CHF-18.85 Million ≈ $-23.83 Million |
-0.048x | -109.50% |
| 2018-12-31 | CHF444.85 Million ≈ $562.42 Million |
CHF-10.16 Million ≈ $-12.85 Million |
-0.023x | -7.32% |
| 2017-12-31 | CHF470.12 Million ≈ $594.35 Million |
CHF-10.01 Million ≈ $-12.65 Million |
-0.021x | -133.50% |
| 2016-12-31 | CHF415.56 Million ≈ $525.38 Million |
CHF26.41 Million ≈ $33.39 Million |
0.064x | +165.40% |
| 2015-12-31 | CHF403.65 Million ≈ $510.32 Million |
CHF-39.23 Million ≈ $-49.59 Million |
-0.097x | -122.27% |
| 2014-12-31 | CHF152.29 Million ≈ $192.53 Million |
CHF66.45 Million ≈ $84.01 Million |
0.436x | +1084.01% |
| 2013-12-31 | CHF220.16 Million ≈ $278.34 Million |
CHF8.11 Million ≈ $10.26 Million |
0.037x | -80.04% |
| 2012-12-31 | CHF124.60 Million ≈ $157.53 Million |
CHF23.00 Million ≈ $29.08 Million |
0.185x | +3.72% |
| 2011-12-31 | CHF63.43 Million ≈ $80.20 Million |
CHF11.29 Million ≈ $14.27 Million |
0.178x | +33.42% |
| 2010-12-31 | CHF58.37 Million ≈ $73.79 Million |
CHF7.79 Million ≈ $9.84 Million |
0.133x | +105.80% |
| 2009-12-31 | CHF59.80 Million ≈ $75.60 Million |
CHF3.88 Million ≈ $4.90 Million |
0.065x | +122.39% |
| 2008-12-31 | CHF43.24 Million ≈ $54.66 Million |
CHF-12.52 Million ≈ $-15.82 Million |
-0.290x | -303.62% |
| 2007-12-31 | CHF35.15 Million ≈ $44.44 Million |
CHF-2.52 Million ≈ $-3.19 Million |
-0.072x | -106.31% |
| 2006-12-31 | CHF5.34 Million ≈ $6.76 Million |
CHF6.08 Million ≈ $7.68 Million |
1.137x | -57.78% |
| 2005-12-31 | CHF631.00K ≈ $797.75K |
CHF1.70 Million ≈ $2.15 Million |
2.694x | +1008.37% |
| 2004-12-31 | CHF-880.00K ≈ $-1.11 Million |
CHF261.00K ≈ $329.97K |
-0.297x | -- |
About COSMO Pharmaceuticals SA
Cosmo Pharmaceuticals N.V., a life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris;… Read more